Finance

Lists
Why is ALXO up 11.26%?
Dive Deeper
ALXO:NASDAQ
ALX Oncology Holdings Inc
US$1.28
+11.26%
(+0.13) 1D
US$1.20
-6.61% (-0.085)
After hours
Closed: ኖቬም 9, 4:00:01 ከሰዓት ጂ ኤም ቲ-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALXO...
Open
US$1.19
High
US$1.29
Low
US$1.15
Mkt. cap
159.83 ሚ
Avg. vol.
1.47 ሚ
Volume
0.00
52-wk high
US$2.66
52-wk low
US$0.86
EPS
-US$1.14
Beta
0.61
Shares outstanding
138.28 ሚ
No. of employees
48
Open
US$1.19
High
US$1.29
Low
US$1.15
Mkt. cap
159.83 ሚ
Avg. vol.
1.47 ሚ
Volume
0.00
52-wk high
US$2.66
52-wk low
US$0.86
EPS
-US$1.14
Beta
0.61
Shares outstanding
138.28 ሚ
No. of employees
48
News stories
From web sources and news partners
About ALX Oncology Holdings Inc
CEO-
Employees48
Founded2015
HeadquartersSouth San Francisco, ካሊፎርኒያ, ዩናይትድ ስቴትስ
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 3 analysts giving stock ratings to ALXO in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ALXO in the last 3 months.
Highest
Current US$1.28
US$5.00 (+289.11%)
Average
US$4.33 (+236.96%)
Lowest
US$4.00 (+211.28%)
Analyst
Recommendation
Action
Price target
Projected
Date
Derek Archila
Wells Fargo
Buy
Maintained
US$5.00
+289.1%
10/16/2026
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
US$4.00
+211.3%
10/01/2026
Allison Bratzel
Piper Sandler
Buy
Maintained
US$4.00
+211.3%
08/17/2026
Sam Slutsky
LifeSci Capital
Hold
Maintained
-
-
08/06/2026
Michael Yee
UBS
Buy
Maintained
US$6.00
+366.9%
05/12/2026
Last report
6 ኦገስ 2026
Fiscal period
Q2 2026
-US$0.11 / -US$0.16
+32.14%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ሴፕቴ 2025
ዲሴም 2025
ማርች 2026
ጁን 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
17.44 ሚ
17.64 ሚ
13.61 ሚ
13.14 ሚ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.09 ሚ
5.38 ሚ
5.36 ሚ
5.13 ሚ
Operating expense
22.53 ሚ
23.02 ሚ
18.97 ሚ
18.27 ሚ
Total operating expenses
22.53 ሚ
23.02 ሚ
18.97 ሚ
18.27 ሚ
Operating income
-22.53 ሚ
-23.02 ሚ
-18.97 ሚ
-18.27 ሚ
Other non operating income
-
-
188.00 ሺ
-
EBT including unusual items
-22.14 ሚ
-22.85 ሚ
-17.93 ሚ
-17.97 ሚ
EBT excluding unusual items
-22.14 ሚ
-22.85 ሚ
-17.93 ሚ
-17.06 ሚ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-22.14 ሚ
-22.85 ሚ
-17.93 ሚ
-17.97 ሚ
Net profit margin
-
-
-
-
Earnings per share
-
-0.37
-0.15
-0.11
Interest and investment income
802.00 ሺ
573.00 ሺ
1.18 ሚ
1.51 ሚ
Interest expense
-408.00 ሺ
-383.00 ሺ
-331.00 ሺ
-285.00 ሺ
Net interest expenses
394.00 ሺ
190.00 ሺ
851.00 ሺ
1.22 ሚ
Depreciation and amortization charges
-
-
-
-
EBITDA
-22.38 ሚ
-22.87 ሚ
-18.82 ሚ
-17.71 ሚ
Gain or loss from assets sale
-
-
-
246.00 ሺ
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google መተግበሪያዎች